Proliferation, migration-associated differentiation, and cell death occur continuously and in a spatially well-organized fashion along the crypt-villus axis of the mouse small intestine, making it an attractive system for studying how these processes are regulated and interrelated.
The adult mouse small intestinal epithelium is an excellent model system to study control of cellular proliferation, differentiation, and death programs. Decisions to divide, to undergo migration-associated differentiation, and to die are made continuously and elaborated in a continuum that extends from the small intestine's crypts to the tips of its villi (for review, see ref. 1) . A readily detectable anatomic unit-the crypt of Lieberkuhn-functions as the proliferative compartment.
Each of the adult intestine's -1.1 million crypts is long-lived (2) and has an average steady-state population of 250 cells, of which 150 are rapidly proliferating (3) . The crypt's epithelial cell census is maintained by one or a few active multipotent stem cell(s) (4) located in a niche near the crypt base. Each crypt contains four to six transit cell generations (3) .
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The multipotent crypt stem cell gives rise to four principal epithelial lineages. Columnar absorptive enterocytes make up >80% of all small intestinal epithelial cells (5) . Goblet cells produce a variety of mucins (6) . Enteroendocrine cells export peptide hormones (7) . Paneth cells secrete antimicrobial cryptdins, digestive enzymes, and growth factors (8) . Each small intestinal crypt supplies cells to several adjacent finger-shaped villi (9, 10) . Members of the enterocytic, goblet, and enteroendocrine lineages differentiate as they are translocated in vertical coherent columns from each crypt up an adjacent villus (11, 12) . They complete their upward journey, enter a death program (13) , and are exfoliated from the villus' apically situated extrusion zone into the intestinal lumen, all within a 2-to 5-day period (14) . In contrast, Paneth cells differentiate during a downward migration to the crypt base where they reside for an average of 23 days before being removed by phagocytosis (15) .
Recent studies indicate that regulation of proliferation, differentiation, and death along the crypt-villus axis is not cell autonomous but, rather, depends upon cell-cell and cellmatrix interactions (16) . In addition, complex cephalocaudal differences in the differentiation programs of the four epithelial cell lineages are established and maintained in the face of their continuous self-renewal. This axial patterning has been illustrated by immunohistochemical methods that used a panel of lectins and monoclonal antibodies (mAbs) raised against defined saccharide units (6). The sensitivity of these reagents as differentiation markers reflects the fact that higher eukaryotic cells produce complex carbohydrates with enormous structural variations (for review, see ref. 17 ). These glycoconjugates are assembled via stepwise transglycosylation reactions catalyzed by cellular glycosyltransferases with complex lineage-specific, developmental, and differentiation-dependent patterns of expression (18, 19) . The regulated expression of glycosyltransferases, selective for specific endogenous oligosaccharide substrates, results in the generation of protein and glycolipid products with a variety of saccharide units and glycosidic linkages.
Cellular glycoconjugates have been implicated as mediators of cell adhesion, diapedesis, and microbial attachment (17, 20) . Recent genetic studies have attempted to define the role of complex carbohydrates in modulating cellular differentiation and organogenesis. A knockout of the mouse Mgat-1 gene encoding UDP-N-acetylglucosamine:a-3-D-mannoside 13-1,2-N-acetylglucosaminyltransferase I, a Golgi enzyme required for subsequent generation of complex N-linked oligosacchaAbbreviations: Le, Lewis; FT, fucosyltransferase; LNT, lacto-Ntetraose; LnNT, lacto-neo-N-tetraose; Ig, immunoglobulin; FITC, fluorescein isothiocyanate; Cy3, Cy3.18-OSu fluorescent cyanin dye; AMCA, aminomethylcoumarin acetate; BrdU, 5'-bromo-2'-deoxyuridine; HSA, human serum albumin; SV40 TAg, simian virus 40 large tumor antigen; mAb, monoclonal antibody; P, postnatal day. fTo whom reprint requests should be addressed.
rides (21) , produces lethality by embryonic day 10 with growth retardation, defects in neural tube morphogenesis, situs inversus, and impaired vascularization (22, 23) . The consequences of deacetylation of 9-O-acetyl sialic acids have been examined in transgenic mice. When the influenza C virus 9-O-acetylsialic acid-specific esterase was placed under the control of the methallothionein promoter, growth arrest occurred at the two-cell stage of development (24) . When the phenylethanolamine-N-methyltransferase promoter was used, there were severe abnormalities in retinal and adrenal gland development and/or organization (24) .
A pathway for producing glycoconjugates, and/or depleting normal endogenous sugar epitopes through utilization of acceptor molecules, has been engineered in the gastrointestinal epithelium of transgenic mice by expressing a human al,3/4-fucosyltransferase (al,3/4-FT; EC 2.4.1.65; ref. 25) . Addition of the al,3/4-FT does not produce any detectable effects on cellular proliferation or differentiation programs (25) . However, introduction of a foreign glycosyltransferase into crypt transit cells and their descendants has provided us with an opportunity to examine the effects of these programs on endogenous oligosaccharide biosynthetic pathways. The two pedigrees were maintained by crosses to normal FVB/N littermates and were also used to generate bitransgenic SV40 TAg x al,3/4-FT animals. Primers and protocols for identifying each of the transgenes using PCR and tail DNA are provided in refs. 25 and 27. FVB/N transgenic mice and their normal nontransgenic FVB/N littermates were housed in microisolator cages in a barrier facility under a strict light cycle (lights on between the hours of 0600 and 1800). Animals were fed a standard irradiated rodent chow diet (Pico) ad libitum. Routine screens for hepatitis, minute, lymphocytic choriomeningitis, ectromelia, polyoma, Sendai, pneumonia, and MAD viruses, enteric bacterial pathogens, and parasites were negative. The specified pathogen-free animals were given an intraperitoneal injection of 5'-bromo-2'-deoxyuridine [BrdU; 120 mg/kg (body weight)] and 5'-fluoro-2'-deoxyuridine (12 mg/kg) 90 min prior to sacrifice at postnatal days (P) 42, 180, and 365 (n = 2-4 animals per time point per group).
MATERIALS AND METHODS
Immunohistochemical Studies. The small intestine was removed en bloc, flushed with Bouin's solution, fixed in Bouin's solution for 12-24 h, washed in 70% ethanol (two 1-day cycles), and divided into thirds. The proximal, middle, and distal segments were designated duodenum, jejunum, and ileum, respectively. Each segment was opened with a longitudinal incision along its mesenteric side, rolled up (16) , and embedded in paraffin. Five-micron-thick sections were prepared, deparaffinized in xylene, rehydrated, and placed in blocking buffer [phosphate-buffered saline, pH 7. chemical studies. The specificities of the mAbs were verified by probing Western blots of purified structurally characterized oligosaccharides conjugated to HSA (Fig. 2 and data not  shown) .
In normal adult P42-P365 FVB/N mice, H type 2 epitopes are confined to Paneth cells and a subpopulation of goblet cells (data not shown). Lex-, Lea-, or Leb_specific mAbs did not react with any crypt-or villus-associated epithelial cell populations. Binding of the LeY mAb is restricted to nonproliferating, differentiated, H type 2-producing Paneth cells located at the crypt base (Fig. 3 A and B ). The cellular distribution of H type 2 and LeY epitopes indicates that members of the goblet-cell lineage contain an endogenous a1,2-FT activity and that Paneth cells contain both al,2-and al,3-FT activities (see Fig.  1 ).
The distribution of H type 2 epitopes along the crypt-villus axis in P42-P365 al,3/4-FT transgenic mice was identical to the distribution in their normal nontransgenic cagemates. Ley production was maintained in Paneth cells (Fig. 3C) . Expression of the human al,3/4-FT leads to production of Ley epitopes in H type 2-positive goblet cells (Fig. 3C ). Lea and Leb glycoconjugates were found in undifferentiated proliferating and nonproliferating crypt cells and in postmitotic villusassociated enterocytes, goblet, and enteroendocrine cells (e.g., (Fig. 3 D-F) . However, Lex was not detectable in differentiated postmitotic villus enterocytes or goblet cells (Fig. 3E) Therefore, an experiment was designed to determine whether postmitotic cells that have already progressed through their migration-associated differentiation program can be induced to generate Lex glycoconjugates when their proliferative status is altered. Nucleotides -1178 to +28 of the rat intestinal fatty acid binding protein gene (Fabpi) have been used to direct production of a variety of proteins in postmitotic villusassociated enterocytes of transgenic mice. Expression is initiated on embryonic day 15, persists through adulthood, and is restricted to differentiated members of the enterocytic lineage (27, 29) . SV40 TAg causes villus enterocytes to reenter the cell cycle (27, 32, 33) . Previous multilabel immunohistochemical analyses using a large panel of lectins and antibodies failed to disclose any changes in the expression of terminal differentiation markers in these proliferating cells when compared to enterocytes located at comparable positions along the cryptvillus and duodenal-ileal axes of age-and gender-matched nontransgenic FVB/N littermates (6 Fig. 3H) .
Remarkably, the bitransgenic mice produce Lex epitopes in their proliferating SV40 TAg-positive villus enterocytes ( Fig.  3 N and 0) , just as they do in their SV40 TAg-negative crypt transit cell population (Fig. 3H) . Blocking controls disclosed that LeX-HSA but not Lea-HSA abolished binding of the Lex mAb to both villus and crypt cells in these bitransgenic animals (data not shown), providing additional evidence for the identity of these epitopes. Fig. 3M illustrates how (Fig. 3M) . The villi were also used to confirm the correlation between reentry of enterocytes into S phase and their production of Lex glycoconjugates.
Finally, multilabeling experiments indicated that the production of LeX glycoconjugates, which occurs as enterocytes reenter the cell cycle, is not accompanied by a loss of Lea epitopes (Fig. 3K) . Coexpression of Lex and Lea in proliferating SV40 TAg-positive enterocytes (Fig. 3 L-N) suggests that reentry into the cell cycle is accompanied by specific changes in endogenous carbohydrate metabolic pathways.
Prospectus. We do not know whether the Lex or Lea products described above are N-or 0-linked glycoproteins or glycolipids. Nonetheless, we believe that the significance of our findings is that genetically engineered pathways for oligosaccharide biosynthesis may be a generally useful and sensitive way of providing markers for progression through the cell cycle, for assessing/operationally defining whether a change in proliferative status affects the state of cellular differentiation, and/or for examining the effects of proliferation and differentiation programs on the activities of endogenous carbohydrate metabolic pathways. Proc. Natl. Acad. Sci. USA 93 (1996) ditional glycoconjugates does not perturb normal cellular function, creating additional oligosaccharide biosynthetic pathways in targeted cell populations may provide a strategy for retrieving them, either by fluorescence-activated cell sorting or by lectin panning, for further study.
